Skip to content

Effect of Intrathecal Hydromorphone on Postoperative Bladder Spasm in Patients Undergoing Transurethral Resection of the Prostate

Effect of Intrathecal Hydromorphone on Postoperative Bladder Spasm in Patients Undergoing Transurethral Resection of the Prostate

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095650
Enrollment
Unknown
Registered
2025-01-09
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

Control group:Patients with spinal anesthesia drugs using ropivacaine alone
Hydromorphone group:Patients with 50µg hydromorphone in combination with spinal anesthesia drugs

Sponsors

Dalian Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who chose our hospital for elective transurethral resection of the prostate, aged >=65 years old, American Society of Anesthesiologists Health Status Classification (ASA) Class I-III. The method of anesthesia is neuraxial anesthesia

Exclusion criteria

Exclusion criteria: Patients with obvious respiratory and circulatory dysfunction before surgery; Patients with abnormal liver and kidney function; Patients with coagulation dysfunction; Those who are allergic to ropivacaine and hydromorphone hydrochloride injection-related ingredients; Infected patients at the puncture site; Spinal trauma or a history of severe low back pain; Those who are mentally ill, severely neurotic, etc., and cannot cooperate

Design outcomes

Primary

MeasureTime frame
Numeric Pain Score (NRS);

Countries

China

Contacts

Public ContactGe Qian

Dalian Third People's Hospital

931782466@qq.com+86 186 4090 8169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026